A multi-cohort phase 1b trial of rituximab in combination with immunotherapy doublets in relapsed/refractory follicular lymphomaReid W. Merryman, Caron A. Jacobson, Jennifer R. Brown et al.|Annals of Hematology|2023Cited by 7
Dual Immune Checkpoint Agents in Combination with Rituximab for Patients with Relapsed or Refractory Follicular LymphomaReid W. Merryman, Caron A. Jacobson, Robert Redd et al.|Blood|2022Cited by 1